Clinical Trials Logo

Filter by:
NCT ID: NCT03188731 Completed - Pregnancy Related Clinical Trials

ZIKAlliance Pregnant Women Cohort

ZIKAlliancePW
Start date: May 24, 2017
Phase:
Study type: Observational

The aim of this proposal is to evaluate the causal relationship between Zika virus (ZIKV) infections in pregnancy and congenital malformations. We will estimate the absolute and relative risks of congenital malformations and other adverse outcomes of pregnancy among women who become infected with ZIKV during pregnancy compared to uninfected pregnant women, also leading to further validation of the Congenital Zika Syndrome.

NCT ID: NCT02862990 Completed - Breast Cancer Clinical Trials

Evaluation of the Attitude of Pre Menopausal Women With Breast Cancer Faced With the Risk of Fertility Loss Caused by Chemotherapy

Start date: May 2015
Phase:
Study type: Observational

To evaluate the attitude of pre menopausal women with breast cancer faced with the risk of loss of fertility caused by chemotherapy using EORTC's Fertility Questionnaire.

NCT ID: NCT02804074 Recruiting - Masked Hypertension Clinical Trials

MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement

MASTER
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

MASTER study is a 4-year prospective, randomized, open-label, blinded-endpoint study (PROBE) comparing 2 management strategies 1) office BP as a guide to treatment, or 2) 24-hour ABP as a guide to treatment. Study objectives are to investigate whether a management strategy based on out-of-office BP (Ambulatory BP monitoring) versus a management strategy based on office BP measurements is associated with differences in outcome, including cardiovascular and renal intermediate end points at one year; cardiovascular events at 4 years and changes in a number of blood pressure-related variables throughout the study. Patients will be followed-up during the first year focusing on changes in left ventricular mass index (LVMI, co-primary endpoint) and Urinary albumin excretion (UAE, albumin/creatinine ratio, co-primary end-point), and during the whole 48 month period for both changes in LVMI and UAE and events including all-cause mortality, CV morbidity and mortality, cerebral morbidity and mortality.A total of 1240 subjects will be recruited by 30 centers, taking into account a dropout rate of 15% (620 subjects per randomization arm).

NCT ID: NCT02768909 Active, not recruiting - Clinical trials for Tuberculosis, Pulmonary

Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB

Start date: January 2015
Phase: N/A
Study type: Interventional

Determine the diagnostic accuracy for pulmonary tuberculosis in adults of the E-Nose in Venezuela.

NCT ID: NCT02765087 Recruiting - Clinical trials for Tuberculosis, Pleural

E-Nose: Diagnostic Tool for Pleural TB

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the diagnostic utility of the device 'Electronic Nose' for Pleural TB, which is a Extra pulmonary TB form, compared with pleural biopsy, the current gold standard.

NCT ID: NCT02758860 Completed - Colonic Diverticula Clinical Trials

Predictive Value of DICA in the Diverticular Disease of the Colon

Start date: June 2016
Phase:
Study type: Observational [Patient Registry]

The Diverticular Inflammation and Complication Assessment (DICA) is an endoscopic classification for diverticulosis and diverticular disease of the colon. The aim of the study is to show that DICA classification is a valid parameter to predict the risk of acute diverticulitis occurrence/recurrence and the need of surgery in patients suffering from diverticulosis/diverticular disease of the colon.

NCT ID: NCT02624141 Terminated - Anemia Clinical Trials

A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Start date: April 2006
Phase: Phase 4
Study type: Interventional

This study will examine the efficacy, safety, and effect on hemoglobin levels, of once weekly epoetin beta subcutaneous injections (30,000 International Units [IU]) in anemic patients with solid tumors. The anticipated study duration is 4 months, and the target sample size is 40 individuals.

NCT ID: NCT02608060 Terminated - Anemia Clinical Trials

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Start date: September 2006
Phase: Phase 4
Study type: Interventional

This study will examine the efficacy, safety and effect on hemoglobin levels, of once weekly subcutaneous injections of epoetin beta (30,000 IU) in anemic participants with non-Hodgkin's lymphoma, chronic lymphocytic leukemia or multiple myeloma. The anticipated study duration is 4 months, and the target sample size is 30 individuals.

NCT ID: NCT02596815 Completed - Clinical trials for Cervicobrachial Neuralgia

Hypoalgesic Effect of Median Nerve Neural Mobilization Compared to a Controlled Group

Start date: July 2015
Phase: N/A
Study type: Interventional

The purpose of these study is to compare the effectivity of the Median Nerve Neural Mobilization technique to the complete absence of treatment in a group of patients who suffer cervicobrachial pain.

NCT ID: NCT02595294 Completed - Clinical trials for Cervicobrachial Neuralgia

Hypoalgesic Effect of Neural Mobilization

Start date: July 2015
Phase: N/A
Study type: Interventional

The purpose of these study is to compare the effectivity of the Cervical Lateral Glide physical therapy neural mobilization technique to the complete absence of treatment in a group of patients who suffer cervicobrachial pain.